0001209191-22-006638.txt : 20220202 0001209191-22-006638.hdr.sgml : 20220202 20220202215803 ACCESSION NUMBER: 0001209191-22-006638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ranalli Tamara A. CENTRAL INDEX KEY: 0001822508 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 22586318 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-31 0 0000353569 QUIDEL CORP /DE/ QDEL 0001822508 Ranalli Tamara A. 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 SVP, Molecular Bus. Unit Common Stock 2022-02-01 4 A 0 473 0.00 A 15154 D Common Stock 2022-02-01 4 F 0 116 102.32 D 15038 D Non-Qualified Stock Option 103.36 2022-01-31 4 A 0 4957 0.00 A 2032-01-31 Common Stock 4957 4957 D Restricted Stock Units 2022-01-31 4 A 0 4958 0.00 A Common Stock 4958 4958 D Restricted Stock Units 2022-01-31 4 A 0 3386 0.00 A Common Stock 3386 3386 D Restricted Stock Units 2022-02-01 4 M 0 473 0.00 D Common Stock 473 1420 D Reflects release of restricted stock units that were previously reported on a Form 4. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. 1,239 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,239 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,239 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,240 shares vest on the fourth anniversary date of the grant date, January 31, 2026. Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. 1,239 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,239 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,240 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,240 shares vest on the fourth anniversary date of the grant date, January 31, 2026. 1,693 shares vest on the second anniversary date of the grant date, January 31, 2024; 846 shares vest on the third anniversary date of the grant date, January 31, 2025; and 847 shares vest on the fourth anniversary date of the grant date, January 31, 2026. One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date. Robert J. Bujarski, attorney-in-fact for Tamara A. Ranalli 2022-02-02